Dashboard Tools Market News Investing Ideas Pricing About Us
Sign Up
Log in
Arcturus Therapeutics Holdings Inc banner

Arcturus Therapeutics Holdings Inc
NASDAQ:ARCT

Watchlist Manager
Arcturus Therapeutics Holdings Inc Logo
Arcturus Therapeutics Holdings Inc
NASDAQ:ARCT
Watchlist
Price: 7.2 USD 0.42% Market Closed
Market Cap: $204.6m
Write Note Create Alert Ask AI
Price Target
Loading...
Revenue
Loading...
Operating Income
Loading...
Net Income
Loading...

Wall Street
Price Targets

ARCT Price Targets Summary
Arcturus Therapeutics Holdings Inc

Wall Street analysts forecast ARCT stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for ARCT is 35.39 USD with a low forecast of 7.07 USD and a high forecast of 75.6 USD.

ARCT Lowest Forecast
Wall Street Target
7.07 USD
-2% Downside
ARCT Average Forecast
Wall Street Target
35.39 USD
392% Upside
ARCT Highest Forecast
Wall Street Target
75.6 USD
950% Upside
Lowest
Price Target
7.07 USD
2% Downside
Average
Price Target
35.39 USD
392% Upside
Highest
Price Target
75.6 USD
950% Upside
Arcturus Therapeutics Holdings Inc Competitors:
Price Targets
OFIX
Orthofix Medical Inc
56% Upside
OFIX
Orthofix Medical Inc
56% Upside

Revenue
Forecast

N/A
Past Growth
21% / Year
Estimated Growth
Estimates Accuracy
-5%
Average Miss
N/A
Past Growth
21% / Year
Estimated Growth
Estimates Accuracy
-5%
Average Miss

The compound annual growth rate of Arcturus Therapeutics Holdings Inc's revenue for the next 4 years is 21%.

What are analyst estimates?

Operating Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-7%
Average Miss
N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-7%
Average Miss

What are analyst estimates?

Net Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-54%
Average Miss
N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-54%
Average Miss

What are analyst estimates?

See Also

Summary
ARCT intrinsic value, competitors valuation, and company profile.
DCF Valuation
ARCT stock valuation using Discount Cash Flow valuation method.
Relative Valuation
ARCT stock valuation using valuation multiples.
Wall Street Estimates
ARCT price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
ARCT stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is ARCT's stock price target?
Price Target
35.39 USD

According to Wall Street analysts, the average 1-year price target for ARCT is 35.39 USD with a low forecast of 7.07 USD and a high forecast of 75.6 USD.

What is Arcturus Therapeutics Holdings Inc's Revenue forecast?
Projected CAGR
21%

The compound annual growth rate of Arcturus Therapeutics Holdings Inc's revenue for the next 4 years is 21%.

Back to Top
ALPHA SPREAD
Follow us
Join more than 317,600+ value investors using Alpha Spread
Create Free Account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2026 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.